My doctor says I will benefit from the new diabetic drug combo –janumet XR. What do you think?

Last week the FDA formally approval of Jentadueto, which is a combination of lingaliptin and metformin. This week, the FDA approved use of janumet XR – which is an extended release combination of stiagliptin and metformin.

Sometimes I wonder if the FDA works for the public or the pharmaceutical industry. Every week newer drugs are approved. Most of these drugs have only been studied by people who have financial interest in these medications.
If your diabetes is well controlled with whatever you are taking, and you are compliant with your medications, I would say forget this new drug. 

Just because a new drug is introduced does not mean it is better. You can rest assured these new drugs are prohibitively expensive- only people who benefit are the people who sell it and the doctors who prescribe it.
My advice- walk, do not smoke, eat right and stick to your old diabetic regimen. This new diabetic combo is definitely not worth it.